Fig. 6. 2D interactions of JAK2 and EGFR-TK complexed with the thiazole-based chalcones and the known drugs. (A–D) JAK2 complexed with compounds 11, 12, 25 and ruxolitinib (E and F) EGFR-TK complexed with compounds 25 and erlotinib.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.